newsfilter
← Latest News
GlobeNewswire·

Zynerba Pharmaceuticals Announces Podium Presentation at the International Society for Autism Research Annual Meeting

DEVON, Pa., May 09, 2022 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced an oral po